回盛生物(300871.SZ)：拟推2026年员工持股计划

Core Viewpoint - The company, Reborn Bio (300871.SZ), has announced an employee stock ownership plan (ESOP) for 2026, aiming to raise a total of up to RMB 3.081 million [1] Summary by Relevant Sections Employee Stock Ownership Plan - The ESOP intends to raise funds not exceeding RMB 3.081 million, with each unit priced at RMB 1.00, and a maximum of 3.081 million units available for subscription [1] - Funding sources for the ESOP will include employees' legal salaries, self-raised funds, and other legally permitted means, with no financial assistance such as loans or guarantees provided by the company to participants [1] - The shares for the ESOP will be sourced from the company's repurchased A-share common stock held in a dedicated securities account [1] Approval and Transaction Method - The ESOP will be subject to approval by the company's shareholders' meeting and will be transferred through legally permitted methods such as non-trading transfers [1] - Upon approval, the ESOP will acquire shares at a price of RMB 15.00 per share from the company's repurchased stock [1]